Poly Medicure Peer Comparison

NSE: POLYMED | BSE: 531768

₹1,700.60

₹-12.00 (-0.70%)

As on 28-Aug-2026 09:44IST

Market cap

₹17,353 Cr

Revenue (TTM)

₹1,997 Cr

P/E Ratio

55.1

P/B Ratio

5.5

Div. Yield

0.2 %

Edit

	Poly Medicure	Nureca	QMS Medical	Alan Scott	Raaj Medisafe
Market cap (₹ Cr)	17,353	305	294	209	145
Revenue (₹ Cr)	1,997	153	183	34	94
Net Profit (₹ Cr)	307.01	4.34	12.72	-4.78	2.37
Net Margin (%)	14.56	2.70	6.90	-13.48	2.51
RoE (%)	10.63	2.29	10.39	-30.48	6.25
Price to Earnings	55.07	70.41	26.98	--	61.12
Price-To-Book	5.45	1.66	--	11.94	2.97

Income Statement (₹ Cr)

	Poly Medicure	Nureca	QMS Medical	Alan Scott	Raaj Medisafe
Operating Revenue	1,875.26	146.96	--	28.69	62.42
Total Income	2,002.19	155.06	--	30.94	62.73
Total Expenditure	1,436.66	146.78	--	26.75	53.90
EBITDA	438.59	0.18	--	1.94	8.52
Depreciation	115.52	2.02	--	3.80	1.45
EBIT	323.08	-1.84	--	-1.86	7.07
Interest	21.42	1.28	--	2.20	2.13
Other Income	126.93	8.10	--	2.25	0.31
Exceptional Items	-6.80	--	--	--	--
Profit before Tax	427.47	4.98	--	-1.82	5.25
Provision for Tax	106.74	2.90	--	--	-0.88
Profit after Tax	320.73	2.08	--	-1.82	6.13

	Poly Medicure	Nureca	QMS Medical	Alan Scott	Raaj Medisafe
Shareholder's Funds	3,106.17	180.76	--	1.77	26.92
Minority Interest	43.07	--	--	-0.58	--
Non-Current Liabilities	120.16	-0.92	--	19.69	13.28
Current Liabilities	666.53	13.78	--	6.37	27.87
Total Liabilities	3,951.60	196.16	--	27.25	69.22

	Poly Medicure	Nureca	QMS Medical	Alan Scott	Raaj Medisafe
Non-Current Assets	1,903.19	78.94	--	18.03	38.44
Current Assets	2,032.74	114.68	--	9.21	29.62
Total Assets	3,951.60	196.16	--	27.25	69.22
Total Debt*	341.62	0.72	--	7.38	34.51
Net Current Assets	1,366.21	100.90	--	2.85	1.75
Contingent Liabilities	50.21	4.73	--	--	0.36

	Poly Medicure	Nureca	QMS Medical	Alan Scott	Raaj Medisafe
Cash From Operating Activities	246.37	3.30	--	-1.68	-0.09
Cash Flow from Investing Activities	-225.38	14.49	--	1.92	-16.42
Cash from Financing Activities	20.15	-19.56	--	-1.98	16.52
Net Cash Inflow / Outflow	41.14	-1.77	--	-1.74	0.02

	Poly Medicure	Nureca	QMS Medical	Alan Scott	Raaj Medisafe
ROCE (%)	14.05	3.31	--	3.64	15.05
ROE (%)	10.94	1.11	--	-71.25	32.48
ROA (%)	8.89	1.04	--	-6.59	11.21
EBIT Margin (%)	30.16	5.63	--	14.60	14.15
Net Margin (%)	16.02	1.34	--	-5.87	9.77
Cash Profit Margin (%)	23.12	2.57	--	6.93	12.14

	Poly Medicure	Nureca	QMS Medical	Alan Scott	Raaj Medisafe
Revenue Growth (%)	12.30	34.02	--	149.39	44.33
EBIT Growth (%)	3.80	69.11	--	1,282.42	31.98
Net Profit Growth (%)	-5.27	145.86	--	48.05	84.20
EPS Growth (%)	-4.88	157.91	--	48.32	52.40
Book Value Growth (%)	12.14	-6.96	--	-46.81	148.37

	Poly Medicure	Nureca	QMS Medical	Alan Scott	Raaj Medisafe
Price / Earnings	37.47	94.46	--	0.00	15.80
Price / Book Value	3.90	1.09	--	36.61	3.60
Dividend Yield (%)	0.29	0.00	--	0.00	0.00
EV/EBITDA	21.79	18.84	--	17.05	14.87
Market Cap (₹ Cr)	12,069.92	196.67	--	64.81	96.86

	Poly Medicure	Nureca	QMS Medical	Alan Scott	Raaj Medisafe
Debt to Equity	0.11	0.00	--	4.17	1.28
Short term debt to equity ratio	0.08	0.00	--	0.16	0.75
Current Ratio	3.05	8.32	--	1.45	1.06
Quick Ratio	2.40	4.88	--	0.79	0.77
Interest Coverage	20.96	4.88	--	0.17	3.47

	Poly Medicure	Nureca	QMS Medical	Alan Scott	Raaj Medisafe
Debtors to sales (%)	28.33	5.27	--	2.17	26.75
Asset Turnover	0.52	0.80	--	1.04	1.14
Receivable days	85.20	12.70	--	6.55	71.88
Inventory Days	69.58	100.27	--	52.69	48.55
Payable days	77.97	22.92	--	33.92	20.86
Cash Conversion Cycle	76.82	90.04	--	25.31	99.57

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.